Sabi Pharmaceutical Private Limited
About Sabi Pharmaceutical Private Limited
Data last updated:
Sabi Pharmaceutical Private Limited is a private limited company based in Gwalior, Madhya Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 09 June 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U24100MP2016PTC040916. Its GSTIN is 23AAXCS2593Q1ZA (Madhya Pradesh).
The company has an authorised share capital of ₹9 Lakh and a paid-up capital of ₹9 Lakh. It is led by directors Bhupendra Tyagi and Sagar Singh Sikarwar.
Its last annual general meeting (AGM) was held on 30 September 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office is at 10 Dwarikadhish Colony Thatipur, Gwalior, Madhya Pradesh, India – 474011.
As per the financials filed for FY 2022, the company reported a revenue of ₹1.3 Lakh, a decline of 63% compared to the previous year. For the same year it recorded a net loss of ₹65,052 (net margin -50.2%) and EBITDA of -₹65,052 (EBITDA margin -50.2%). Revenue has grown at a compounded annual rate (CAGR) of 16% over three years and 29% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Sabi Pharmaceutical Private Limited's registered office is in Gwalior, Madhya Pradesh. Its e-mail address is in the company report.
- Email
- Registered Address10 Dwarikadhish Colony Thatipur, Gwalior, Madhya Pradesh, India – 474011
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Sabi Pharmaceutical Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Sabi Pharmaceutical is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Sabi Pharmaceutical Private Limited, buy the company report.
Financials of Sabi Pharmaceutical Private Limited
FY 2022 filings availableSabi Pharmaceutical Private Limited reported revenue of ₹1.3 Lakh (down 63% YoY) for FY 2022.
Compounded Annual Growth Rate (CAGR)
Revenue fell 63% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 29%. EBITDA fell 23% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹65,052 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹65,052 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -50.2% | ||||
| Net Profit Margin | -50.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Sabi Pharmaceutical Private Limited, buy the company report.
Board of directors of Sabi Pharmaceutical Private Limited
Sabi Pharmaceutical has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Bhupendra Tyagi | Director | 09 Jun 2016 | 10 Years 4 Months | Current |
| Sagar Singh Sikarwar | Director | 09 Jun 2016 | 10 Years 4 Months | Current |
Peer comparison
Sabi Pharmaceutical Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Hanukind Lifesciences Private Limited | ₹1.32 Lakh (FY 2025) | -69.0% | Selaqui, Uttarakhand, India | |||
| Shreeneel Chemicals Private Limited | ₹1.3 Lakh (FY 2025) | -96.0% | Bharuch, Gujarat, India | |||
| Debon Herbals Private Limited | ₹1.3 Lakh (FY 2025) | -85.0% | Thane, Maharashtra, India | |||
| Varona HK Medical India Private Limited | ₹1.3 Lakh (FY 2021) | Nagpur, Maharashtra, India | ||||
| SVD Ventures Private Limited | ₹1.3 Lakh (FY 2025) | -99.0% | Rewa, Madhya Pradesh, India | |||
| Sabi Pharmaceutical Private Limitedthis company | ₹1.3 Lakh (FY 2022) | -₹65,052 | -50.2% | -63.0% | Gwalior, Madhya Pradesh, India | |
| Basal Agribiotech Private Limited | ₹1.29 Lakh (FY 2021) | -83.0% | Balrampur, Uttar Pradesh, India | |||
| Solura Biotech Private Limited | ₹1.29 Lakh (FY 2024) | 330.0% | Vadodara, Gujarat, India | |||
| Sequin Chemicals Pvt Ltd | ₹1.29 Lakh (FY 2016) | -77.0% | Kolkata, West Bengal, India | |||
| Vishal Industries and Chemicals Pvt Ltd | ₹1.29 Lakh (FY 2021) | 0.0% | Mumbai, Maharashtra, India | |||
| SS Pharmalabs Private Limited | ₹1.29 Lakh (FY 2025) | -14.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Sabi Pharmaceutical Private Limited, buy the company report.
Auditor
Sabi Pharmaceutical Private Limited is audited by AMITSURESHAGARWAL& CO for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| AMITSURESHAGARWAL& CO | FY 2017 | 015995C |
Shareholding
The shareholding of Sabi Pharmaceutical Private Limited is on record for FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Sabi Pharmaceutical Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Sabi Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sabi Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Sabi Pharmaceutical has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 23AAXCS2593Q1ZA | Madhya Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Sabi Pharmaceutical Private Limited, buy the company report.
Recent activity
Sabi Pharmaceutical Private Limited has 2 board changes on record since 2016: 2 appointments. The latest: Bhupendra Tyagi was appointed as Director on 09 Jun 2016.
Frequently asked questions
Sabi Pharmaceutical is an active private limited company based in Gwalior, Madhya Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 09 June 2016 (10+ years old) and is registered under CIN U24100MP2016PTC040916.
Sabi Pharmaceutical has 2 current directors:
- Bhupendra Tyagi - Director
- Sagar Singh Sikarwar - Director
The latest financial statements of Sabi Pharmaceutical on record with the MCA are for the year ended 31 March 2022. Its last annual general meeting was held on 30 September 2022. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Sabi Pharmaceutical is 23AAXCS2593Q1ZA, registered in Madhya Pradesh.
The CIN (Corporate Identification Number) of Sabi Pharmaceutical is U24100MP2016PTC040916. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sabi Pharmaceutical was incorporated on 09 June 2016, making it 10+ years old. It is registered with the Registrar of Companies, Gwalior.
The peers of Sabi Pharmaceutical by revenue are Hanukind Lifesciences Private Limited, Shreeneel Chemicals Private Limited, Debon Herbals Private Limited, Varona HK Medical India Private Limited, SVD Ventures Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Bhupendra Tyagi was appointed as Director on 09 Jun 2016. Sagar Singh Sikarwar was appointed as Director on 09 Jun 2016.
The registered office of Sabi Pharmaceutical is at 10 Dwarikadhish Colony Thatipur, Gwalior, Madhya Pradesh, India – 474011.
Sabi Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Sabi Pharmaceutical is compliant as of 18 July 2026. The company is actively filing with the Registrar of Companies.